The bottom line, all of us TBMs are all in big pharma hell here. We are all sticking around to see what the Sota data looks like in July. If it's good, we try to stick around for someone to save us with a buyout, if it's bad or average, this place will be a ghost town. That is real talk...
Preach on! Couldn't say it any better! Cheers to July data for Sanofi to save us all or "it's on to the next one"! Jay Z style!!
Organon audit- amazing what lack of notebooks will do (if I recall correctly) with the SGLT1/2 from selective to dual acting in a single day- look at the wiki page history LXRX doesn't lie- just doesn't understand truth
Think positive. Sanofi bought in because sota data in PIIs were excellent. These guys are not absolutely stupid there to invest hundreds of millions in current PIIIs. Takeover will come shortly before data are disclosed, as usual....Right, Lexicon reps will not be needed there ...
where are the MULTIPLE drugs promised GENENOME5000 long live the hype....... btw SGLT1 accounts for 10% of total reuptake...... from selective to dual in one easy WIKI change gotta love the company